Skip to main content

Table 3 Prognostic factors for T2 gallbladder cancer patients (n = 81)

From: Validation of the oncologic effect of hepatic resection for T2 gallbladder cancer: a retrospective study

Variables

Univariate analysis

Multivariate analysis

HR

95% CI

p value

HR

95% CI

p value

Female sex

1.403

0.376–5.232

0.614

   

Age > 60 years

1.489

0.308–7.205

0.621

   

Overweight (BMI > 25 kg/m2)

1.632

0.437–6.093

0.466

   

CEA (> 5 ng/mL)

6.328

1.134–35.320

0.035

3.608

0.556–23.395

0.179

CA19-9 (> 37 U/mL)

26.762

0.010–68,340.593

0.412

   

Further resection

0.700

0.175–2.801

0.614

   

GB stone

1.625

0.203–13.005

0.647

   

Tumor size (> 10 mm)

24.395

0.003–202,140.970

0.488

   

T stage (T2a vs. T2b)

6.515

0.814–52.138

0.077

3.246

0368–28.624

0.289

Node metastasis

9.336

2.295–37.985

0.002

9.336

2.295–37.985

0.002

Complication

1.467

0.303–7.095

0.634

   

Adjuvant chemotherapy

1.717

0.426–6.925

0.447

   

Laparoscopic surgery

0.822

0.204–3.309

0.783

1.130

0.247–5.167

0.875

  1. BMI body mass index, GB gallbladder, CEA carcinoembryonic antigen, CA19-9 carbohydrate antigen 19-9
Back to article page

World Journal of Surgical Oncology

ISSN: 1477-7819

Contact us